Videoconference with Mr. Takashi Nagao, new president of Medicago Canada (December 18, 2020)


On December 18, Consul General Izawa virtually greeted the new president of Medicago Canada, Mr. Takashi Nagao. Medicago is a biopharmaceutical company that develops vaccines and antibody medicine through a technology which uses living plants to produce proteins. Holding 70% of its shares, Japan’s Mitsubishi Tanabe Pharmaceutical Corporation is the majority shareholder.